Cited by 137Lysosomal Storage Disorders ResearchGlycogen Storage Diseases and MyoclonusGlycosylation and Glycoproteins Research

Transport of human lysosomal neuraminidase to mature lysosomes requires protective protein/cathepsin A

Open access
van der Spoel, Aarnoud, Bonten, Erik, d'Azzo, Alessandra·1998·The EMBO Journal

Abstract

Human lysosomal N-acetyl-alpha-neuraminidase is deficient in two lysosomal storage disorders, sialidosis, caused by structural mutations in the neuraminidase gene, and galactosialidosis, in which a primary defect of protective protein/cathepsin A (PPCA) leads to a combined deficiency of neuraminidase and beta-D-galactosidase. These three glycoproteins can be isolated in a high molecular weight multi-enzyme complex, and the enzymatic activity of neuraminidase is contingent on its interaction with PPCA. To explain the unusual need of neuraminidase for an auxiliary protein, we examined, in transfected COS-1 cells, the effect of PPCA expression on post-translational modification, turnover and intracellular localization of neuraminidase. In pulse-chase studies, we show that the enzyme is synthesized as a 46 kDa glycoprotein, which is poorly phosphorylated, does not undergo major proteolytic processing and is secreted. Importantly, its half-life is not altered by the presence of PPCA. However, neuraminidase associates with the PPCA precursor shortly after synthesis, since the latter protein co-precipitates with neuraminidase using anti-neuraminidase antibodies. We further demonstrate by subcellular fractionation of transfected cells that neuraminidase segregates to mature lysosomes only when accompanied by wild-type PPCA, but not by transport-impaired PPCA mutants. These data suggest a novel role for PPCA in the activation of lysosomal neuraminidase, that of an intracellular transport protein.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/emboj/17.6.1588

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the absence of functional PPCA, NEU1 is retained in the endosomal compartment while the pool of β-GAL reaching lysosomes is rapidly degraded; formation of the PPCA/NEU1/β-GAL complex has a reciprocal advantage for the three enzymes, which acquire active and stable conformation in lysosomes.

    “In absence of functional PPCA, NEU1 is retained in the endosomal compartment while the pool of β-GAL reaching the lysosomes is rapidly degraded 36.”

    From Galactosialidosis: historic aspects and overview of investigated and emerging treatment options (2017) · cites this paper as [39]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • CTSA facilitates the transport of NEU1 to lysosomes.

    “It facilitates the transport of NEU1 to lysosomes (33), protects it from proteolytic degradation (30), and was suggested to induce a conformational change in NEU1, enabling its enzymatic activity (12, 22, 30, 33).”

    From Structure of the immunoregulatory sialidase NEU1 (2023) · cites this paper as [33]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 8

  1. 'Azzo,A., Hoogeveen,A., Reuser,A.J., Robinson,D. and Galjaard,H. (1982) Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man. Proc. Natl Acad. Sci. USA, 79, 4535-4539.
  2. Azzo,A., Andria,G., Strisciuglio,P. and Galjaard,H. (1995) Galactosialidosis. In Scriver,C.R., Beaudet,A.L., Sly,W.S. and Valle,D. 1596 (eds), The Metabolic and Molecular Bases of Inherited Disease. McGraw Hill Inc., New York, pp. 2825-2838.
  3. Reuter,G. and Gabius,H.-J. (1996) Review: sialic acids: structure- analysis-metabolism-occurrence-recognition. Biol. Chem. Hoppe Seyler, 377, 325-342.
  4. Sabatini,D. and Adesnik,M. (1995) The biogenesis of membranes and organelles. In Scriver,C.R., Beaudet,A.L., Sly,W.S. and Valle,D. (eds) The Metabolic and Molecular Bases of Inherited Disease. McGraw Hill Inc., New York, pp. 459-553.
  5. Saito,M. and Yu,R.K. (1995) Biochemistry and function of sialidases. In Rosenberg,A. (ed.), Biology of the Sialic Acids. Plenum Press, New York, pp. 261-313.
  6. Schauer,R., Kelm,S., Reuter,G., Roggentin,P. and Shaw,L. (1995) Biochemistry and role of sialic acids. In Rosenberg,A. (ed.), Biology of the Sialic Acids. Plenum Press, New York, pp. 7-67.
  7. Suzuki,Y., Sakuraba,H. and Oshima,A. (1995) β-Galactosidase deficiency (β-galactosidosis): G M1 -gangliosidosis and Morquio B disease. In Scriver,C., Beaudet,A., Sly,W. and Valle,D. (eds), The Metabolic and Molecular Bases of Inherited Disease. McGraw Hill, Inc., New York, pp. 2785-2824.
  8. Thomas,G.H. and Beaudet,A.L. (1995) Disorders of glycoprotein degradation and structure: α-mannosidosis, β-mannosidosis, fucosidosis, sialidosis, aspartylglucosaminuria and carbohydrate- deficient glycoprotein syndrome. In Scriver,C.R., Beaudet,A.L., Sly,W.S. and Valle,D. (eds), The Metabolic and Molecular Bases of Inherited Disease. McGraw Hill, Inc., New York, pp. 2529-2561.

Cited by

Sorted by citations

Authors
van der Spoel, A., Bonten, E., & d'Azzo, A.
Affiliations
St. Jude Children's Research Hospital (US)
Corresponding author
d'Azzo, Alessandra
Venue
The EMBO Journal
Published
1998-03-16
Volume
17
Issue
6
Pages
1588-1597
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2124325580
Cited by
137
References
0
Citations by year
2026: 1 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 4 · 2021: 6 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 3 · 2016: 3 · 2015: 1 · 2014: 7 · 2013: 7 · 2012: 5
FWCI
4.55
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Lebanese Syrian Associated Charities
  • National Institutes of Health
Topics
  • Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
  • Health Sciences › Medicine › Rheumatology › Glycogen Storage Diseases and Myoclonus
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
Keywords
sialidosis, galactosialidosis, lysosomal storage disease, enzyme maturation, lysosomal trafficking, intracellular trafficking, post-translational modification, enzyme phosphorylation, proteolytic processing, enzyme turnover, enzyme secretion, multienzyme complex, lysosomes
MeSH terms
Animals, Biological Transport, Carboxypeptidases, Cell Fractionation, Enzyme Activation, Humans, Lysosomes, Molecular Weight, Neuraminidase, Phosphorylation, Protein Precursors, Protein Processing, Post-Translational, Transfection, DNA, Complementary, COS Cells, Cathepsin A

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review